Takeda Pharmaceutical (TAK) Current Taxes (2018 - 2025)
Historic Current Taxes for Takeda Pharmaceutical (TAK) over the last 8 years, with Q4 2025 value amounting to $963.7 million.
- Takeda Pharmaceutical's Current Taxes fell 811.74% to $963.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $963.7 million, marking a year-over-year decrease of 811.74%. This contributed to the annual value of $876.4 million for FY2025, which is 1499.62% up from last year.
- As of Q4 2025, Takeda Pharmaceutical's Current Taxes stood at $963.7 million, which was down 811.74% from $834.2 million recorded in Q3 2025.
- Takeda Pharmaceutical's 5-year Current Taxes high stood at $1.9 billion for Q2 2022, and its period low was $741.6 million during Q1 2024.
- Moreover, its 5-year median value for Current Taxes was $1.2 billion (2022), whereas its average is $1.3 billion.
- Examining YoY changes over the last 5 years, Takeda Pharmaceutical's Current Taxes showed a top increase of 3787.57% in 2024 and a maximum decrease of 5778.45% in 2024.
- Quarter analysis of 5 years shows Takeda Pharmaceutical's Current Taxes stood at $1.6 billion in 2021, then decreased by 18.09% to $1.3 billion in 2022, then crashed by 43.07% to $760.7 million in 2023, then skyrocketed by 37.88% to $1.0 billion in 2024, then decreased by 8.12% to $963.7 million in 2025.
- Its Current Taxes stands at $963.7 million for Q4 2025, versus $834.2 million for Q3 2025 and $1.0 billion for Q2 2025.